India Begins Commercial Exports of Covid-19 Vaccine
Published On Jan 22, 2021 12:00 AM By Yamini Sharma
According to reports, the government of India has finally cleared commercial export of Covid-19 vaccine. In regards to the news, the Indian foreign secretary informed that the first consignment of coronavirus vaccines will be shipped to Brazil and Morocco on January 22. It must be noted that the vaccine shots were developed by AstraZeneca & Oxford University originally, the Indian version of which was developed at the Serum Institute of India. The latter had received multiple orders from various countries across the globe.zz
Until now, the Indian government had withheld the export of novel coronavirus vaccine doses. This export has only begun after India commenced its own domestic immunisation programme last weekend. Free covid-19 vaccines were supplied from India to neighbouring countries, including Nepal, Bhutan, Maldives, and Bangladesh earlier this week.
Harsh Vardhan Shringla, Foreign Secretary stated that the commercial supplies of the vaccine will begin on Friday following the Indian Prime Minister's commitment to make use of India's production capacities for the best of all humanity to battle the deadly virus. He confirmed that the supply of commercially contracted quantities will start from January 22, starting with Brazil and Morocco. South Africa and Saudi Arabia will follow next in the line.
Brazil has been requesting India for the AstraZeneca-Oxford coronavirus vaccine. The country has agreed to get 2 million doses from Serum Institute and was even prepared to send a plane last week to pick up the vaccines. As per the report by the officials, Serum Institute has secured supplies for Morocco, South Africa and Saudi Arabia as well.
You May Also Like To Read: New Coronavirus Strain? What is it?
Disclaimer: This article is issued in the general public interest and meant for general information purposes only. Readers are advised not to rely on the contents of the article as conclusive in nature and should research further or consult an expert in this regard.